This facility was established in 2010 by Cyclopharm Limited. The facility was originally designed to enable 18F production for routine synthesis products together with 64Cu and 89Zr isotopes for research. In 2016, the facility ceased operations. Cyclotek, Cyclopharm and Macquarie University have since negotiated a position whereby Cyclotek has use of the assets and facility for 10+ years to develop and enhance radiopharmaceuticals for New South Wales but also Australia and international markets. Cyclotek NSW Pty Ltd officially took over this facility on the 2nd January 2019.